Related references
Note: Only part of the references are listed.Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
P. M. L. H. Vencken et al.
ANNALS OF ONCOLOGY (2011)
Therapeutic Approaches for Women Predisposed to Breast Cancer
Katherine L. Nathanson et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Preventive therapy for breast cancer: a consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
Bilateral prophylactic mastectomy in women with inherited risk of breast cancer - Prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery
Jessica Gahm et al.
BREAST (2010)
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
Kerryn W. Reding et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
Dorina M. van der Kolk et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction
Antonis C. Antoniou et al.
CANCER RESEARCH (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Daniel P. Silver et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study
Adriana J. Rijnsburger et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
BRCA mutations in the management of breast cancer: the state of the art
Steven A. Narod
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Prophylactic mastectomy for the prevention of breast cancer
Liz Lostumbo et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers
Mary S. Beattie et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2009)
BRCA1 and implications for response to chemotherapy in ovarian cancer
Jennifer E. Quinn et al.
GYNECOLOGIC ONCOLOGY (2009)
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Monika K. Graeser et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation:: The hereditary breast cancer clinical study group
Kelly A. Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer:: A multicenter, prospective study
Noah D. Kauff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
BRCAness Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations
David S. P. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
M. Kriege et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases
C. T. M. Brekelmans et al.
EUROPEAN JOURNAL OF CANCER (2007)
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
LJ Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers
JL Kramer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer risk following bilateral oophorectorny in BRCA1 and BRCA2 mutation carriers:: An international case-control study
A Eisen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (Paclitaxel)-induced cytotoxicity
JA Menendez et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
KA Metcalfe et al.
GYNECOLOGIC ONCOLOGY (2005)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
M Kriege et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mammography benefit in the Canadian National Breast Screening Study-2: A model evaluation
AJ Rijnsburger et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
A note on competing risks in survival data analysis
JM Satagopan et al.
BRITISH JOURNAL OF CANCER (2004)
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients
MD Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
LC Verhoog et al.
BRITISH JOURNAL OF CANCER (2000)
First experiences in screening women at high risk for breast cancer with MR imaging
MMA Tilanus-Linthorst et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
